Quantitative myelin water assessment for multiple sclerosis using multi‐inversion magnetic resonance fingerprinting
Medical Physics · 2025-01 · 52 (1) · 433-443
DOI: 10.1002/mp.17461 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Physics, online erschienen am 10.10.2024. Verfasst von Yingying Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, The University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Multiple Sclerosis, Myelin Sheath, Magnetic Resonance Imaging, Water. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Hong Kong HMRF.
Abstract (Originalsprache)
Background
Multiple sclerosis (MS) is a demyelination disease. Myelin water is a biomarker of myelin and thus myelin water imaging is a vital tool to provide insight into the demyelination process.
Purpose
This study aimed to characterize the multiple compartments including myelin water fraction (MWF), gray matter (GM) cellular water, white matter (WM) cellular water, and cerebrospinal fluid (CSF) using multiple inversion recovery (mIR) magnetic resonance fingerprinting (MRF) on a clinical MS cohort.
Methods
The Phantom experiment was conducted with tubes containing different WM and GM concentrations extracted from pig brains. For the in‐vivo experiment, 23 healthy control (HC) volunteers and 18 MS patients were recruited for this study. The experiments were performed using a clinical 3T MRI. A multi‐slice, fast imaging with a steady‐state precession (FISP) based mIR MRF protocol was used to obtain the MWF measurements, with 6 min of scan time for each volunteer. The quantification was based on the iterative non‐negative least squares (NNLS) with reweighting. The brain compartments quantified were myelin water, WM cellular water, GM cellular water, and CSF. A radiologist with 6 years of experience labeled the MS lesions on FLAIR, MPRAGE, and MWF. Statistical analysis was performed by applying unpaired and paired student's t ‐tests to compare the MWF results in different groups and in normal‐appearing white matter (NAWM) and MS lesions.
Results
The phantom result demonstrated the ability to detect MWF with various myelin concentrations. The maps derived from mIR MRF, including MWF, WM cellular water, GM cellular water, and CSF were consistent with the anatomical structures observed in FLAIR and MPRAGE. The MWF values in the NAWM of MS patients were significantly different from those in HC, with values of 0.32 ± 0.025 and 0.25 ± 0.036, respectively. Additionally, the MWF values in WM lesions were significantly smaller than in NAWM at 0.034 ± 0.036.
Conclusion
The mIR‐MRF technique, using multi‐compartment analysis, can simultaneously generate maps of MWF, WM cellular water, GM cellular water, and CSF with sufficient brain coverage and in a reasonably short scan time. The MWF map might provide insights into the demyelination associated with MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Radiology, The University of Hong Kong, Hong Kong, China.
- Department of Medicine, The University of Hong Kong, Hong Kong, China.
Förderung
- Hong Kong HMRF
Zitieren
APA
Lin, Y., Chan, K. H., Mak, H. K., Yau, K. X., & Cao, P. (2025). Quantitative myelin water assessment for multiple sclerosis using multi‐inversion magnetic resonance fingerprinting. Medical Physics, 52(1), 433-443. https://doi.org/10.1002/mp.17461
Vancouver
Lin Y, Chan KH, Mak HK, Yau KX, Cao P. Quantitative myelin water assessment for multiple sclerosis using multi‐inversion magnetic resonance fingerprinting. Medical Physics. 2025;52(1):433-443. doi:10.1002/mp.17461
BibTeX
@article{Lin2025,
author = {Lin, Yingying and Chan, Koon-Ho and Mak, Henry Ka-Fung and Yau, Krystal Xiwing and Cao, Peng},
title = {Quantitative myelin water assessment for multiple sclerosis using multi‐inversion magnetic resonance fingerprinting},
journal = {Medical Physics},
year = {2025},
volume = {52},
number = {1},
pages = {433--443},
doi = {10.1002/mp.17461}
}
EUVIMED